Neurodegenerative diseases like Parkinson's and Alzheimer's are characterized by irreversible neuron damage and limited ...

But the three-story NYC watering hole steps from Pier 17 at South Street Seaport was also home to a fascinating talk on ...

In a new study, researchers from the University of Copenhagen have successfully created stem cells that are better at ...

A novel study has unveiled a technique that enhances stem cell therapy for neurodegenerative diseases by combining magnetic ...

The comprehensive analytical platform uses laser technology to analyze CAR T cells and has already revealed ways to optimize ...

To that end, BlueRock Therapeutics, a subsidiary of Bayer AG that licensed Memorial Sloan Kettering’s stem cell technology, has begun a Phase 3 trial to test its treatment in roughly 100 people.

Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research & production of cell-based pharmaceuticals – developed based on artificial platelet technology from ...